Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s stock price passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of GBX 56.61 and traded as high as GBX 57.50. Beximco Pharmaceuticals shares last traded at GBX 55.66, with a volume of 27,401 shares changing hands.
Beximco Pharmaceuticals Trading Down 0.4%
The company has a current ratio of 4.13, a quick ratio of 0.37 and a debt-to-equity ratio of 5.27. The firm has a market cap of £242.24 million, a price-to-earnings ratio of 0.03 and a beta of 0.25. The company has a fifty day moving average price of GBX 56.64 and a 200-day moving average price of GBX 48.45.
About Beximco Pharmaceuticals
Beximco Pharma is a leading manufacturer and exporter of medicines based in Bangladesh. Incorporated in 1976, the Company started its operation by importing products from Bayer, Germany and Upjohn, USA and selling them in the local market. In 1980, Beximco Pharma began manufacturing of these products under licensing arrangement and in 1983 launched its own formulation brands. Since its inception, the Company remains committed to health and wellbeing of people across all the continents by providing access to contemporary medicines.
Read More
- Five stocks we like better than Beximco Pharmaceuticals
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
